BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakamura T, Isoda N, Sakoda Y, Harashima H. Strategies for fighting pandemic virus infections: Integration of virology and drug delivery. J Control Release 2022:S0168-3659(22)00068-2. [PMID: 35122872 DOI: 10.1016/j.jconrel.2022.01.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang J, Sun D, Wang M, Cheng A, Zhu Y, Mao S, Ou X, Zhao X, Huang J, Gao Q, Zhang S, Yang Q, Wu Y, Zhu D, Jia R, Chen S, Liu M. Multiple functions of heterogeneous nuclear ribonucleoproteins in the positive single-stranded RNA virus life cycle. Front Immunol 2022;13:989298. [DOI: 10.3389/fimmu.2022.989298] [Reference Citation Analysis]
2 Mangkunegara IS, Purwono P. Analysis of DNA Sequence Classification Using SVM Model with Hyperparameter Tuning Grid Search CV. 2022 IEEE International Conference on Cybernetics and Computational Intelligence (CyberneticsCom) 2022. [DOI: 10.1109/cyberneticscom55287.2022.9865624] [Reference Citation Analysis]
3 Yamada Y, Sato Y, Nakamura T, Harashima H. Innovative cancer nanomedicine based on immunology, gene editing, intracellular trafficking control. J Control Release 2022;348:357-69. [PMID: 35623492 DOI: 10.1016/j.jconrel.2022.05.033] [Reference Citation Analysis]
4 Yamada Y, Ishizuka S, Arai M, Maruyama M, Harashima H. Recent advances in delivering RNA-based therapeutics to mitochondria. Expert Opin Biol Ther 2022;:1-11. [PMID: 35543589 DOI: 10.1080/14712598.2022.2070427] [Reference Citation Analysis]
5 Nakamura T, Kawakami K, Nomura M, Sato Y, Hyodo M, Hatakeyama H, Hayakawa Y, Harashima H. Combined nano cancer immunotherapy based on immune status in a tumor microenvironment. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.03.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]